Research output per year
Research output per year
Personal profile
Research
I conduct research in diabetes with a special focus on late diabetic complications. Using beetle diagnostic methods, my goal is to investigate the mechanisms behind the diseases. My research contributes to persons with diabetes achieving better protection against and treatment of late diabetic complications.
Profile
As a doctor, I am particularly interested in endocrinology. In my daily work, I primarily deal with patient-centered and clinical work in hospitals. I am currently specializing in endocrinology and have previously obtained a PhD degree in medicine.
Areas of expertise
- Endocrinology
- Diabetes
- Late diabetic complications
Fingerprint
Dive into the research topics where Søren Gullaksen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Colchicine mitigates arterial stiffness in high-risk patients with type 2 diabetes: A randomized placebo-controlled trial
Baier, J. M., Funck, K. L., Vernstrøm, L., Gullaksen, S., Laugesen, E. & Poulsen, P. L., 2025, (E-pub / Early view) In: European Journal of Preventive Cardiology. zwaf143Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
-
Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial
Gullaksen, S., Vernstrøm, L., Sørensen, S. S., Funck, K. L., Petersen, L., Bek, T., Poulsen, P. L. & Laugesen, E., Jun 2025, In: Journal of Diabetes and its Complications. 39, 6, 109039.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial
Vernstrøm, L., Gullaksen, S., Sørensen, S. S., Ringgaard, S., Laustsen, C., Birn, H., Funck, K. L., Laugesen, E. & Poulsen, P. L., Oct 2024, In: Diabetologia. 67, 10, p. 2175-2187 13 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access1 Citation (Scopus) -
Metabolic Communication by SGLT2 Inhibition
Billing, A. M., Kim, Y. C., Gullaksen, S., Schrage, B., Raabe, J., Hutzfeldt, A., Demir, F., Kovalenko, E., Lassé, M., Dugourd, A., Fallegger, R., Klampe, B., Jaegers, J., Li, Q., Kravtsova, O., Crespo-Masip, M., Palermo, A., Fenton, R. A., Hoxha, E. & Blankenberg, S. & 15 others, , Mar 2024, In: Circulation. 149, 11, p. 860-884 25 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access68 Citations (Scopus) -
Semaglutide does not affect central retinal thickness beyond the effect explained by glycaemic change: continuous glucose monitoring in persons with type 2 diabetes
Gullaksen, S., Funck, K. L., Bek, T., Sørensen, S. S., Poulsen, P. L., Vernstrøm, L., Petersen, L. & Laugesen, E., 12 Sept 2024, In: Diabetologia. Suppl. 1, 1-593 (2024)Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference article › Research › peer-review
Open Access
Activities
- 1 Participation in or organisation af a conference
-
58th EASD Annual Meeting of the European Association for the Study of Diabetes
Gullaksen, S. (Participant)
19 Sept 2022 → 23 Sept 2022Activity: Participating in or organising an event types › Participation in or organisation af a conference